✦ LIBER ✦

Ifosfamide (IFO)+vinorelbine (VRL) as treatment for advanced, non operable non small cell lung cancer (NSCLC)

✍ Scribed by Pawel, J.v.; Schroeder, M.; Grole-Kiehn, J.; Kerpel-Fronius, S.; Tresca, P.; Westerhausen, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

310 Radiochemotherapy (RT) of advanced n

✍ Schraube, P.; Manegold, Ch.; Latz, D.; Bischoff, H.; Wannenmacher, M.; Drings, P 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Vinorelbine (VNB) + ifosfamide (IFX) in

✍ Rivero, O.; Lozano, M.; Polera, J.; Matiewjuk, M.; Bonicatto, S.; Callejas, C.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Vinorelbine (VNR), ifosfamide (IFO) and

✍ Montalar, J; Morales, S; Vadell, C; Maestu, I; Torregrosa, M.D; Garcia-Gomez, R; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 263 KB

Ifosfamide and vinorelbine in advanced n

✍ Masters, Gregory A.; Hoffman, Philip C.; Samuels, Brian L.; Golomb, Harvey M.; V 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Ifosfamide bolus therapy for advanced no

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Ifosfamide and gemcitabine in advanced n

✍ Gatzemeier, O.; Manegold, C.; Eberhard, W.; Wilke, H.; Chomy, F.; Chomy, P.; Kha 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 90 KB